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LETTER TO THE EDITOR 
Sunscreen And Immunosuppression 
To the Editor: 
Recently, Walker and Young (1997) reported that ultraviolet (UV) 
B sunscreens offer the same UVB protection factors against inflam-
mation and immunosuppression in the mouse . The authors studied 
the relationship between photoprotection of inflammation and 
immunosuppression with monochromatic (Phi lips TL-01 tubes, 
A..,. _,= 311mll) UVB radiation. T he UVB dose-response curve for 
murine edema was similar to that for human erythema . T he 
protection afforded by the UVB fi lters, octyl dimethyl para-
aminobenzoic acid and 2-ethylhexyl-4'-methoxycinnamate (2-
EHMC), revealed that topical or tape application of sunscreen 
protected totally agai11st UV-induced inflammation but onJy par-
tiail y against UV-indu ced immunosuppressio n. Furthermore, a sun 
protection factor (SPF) of 4, i11 vi 11o, was determined for 2-EHMC 
for both inflammation and immunosuppression. 
These fu1d ings , however, are confu sing. On the one hand , the 
investigators used minimally significant increases in skin edema or 
suppression of contact hypersensitivity (CHS) to de fin e minimal 
inflammatory (MID) and minimal immunosuppressive doses 
(MISD) (p < 0.05). In both unprotected and 2-EHMC-protected 
mice , the MID and MISD w ere th e same and w ere determined to 
be 773 mj / cm2 and 3091m]/cm2 , respectively. On the other hand, 
the comparison of protective effects of UVB sunscreens showed 
that 2-EHMC-treated mice exposed to 2.8 MID (2184 mjlcm2 ) 
showed significant suppression of CHS (33%) when compared to 
unirradiated and untrea ted controls (p < 0.05). Dose-reponse 
studies with 2-EI-IMC, however, showed that irradiation with 
about 2150 mj /cm 2 resulted in less than 10% suppression ofCHS. 
W e recently conducted a study regarding the protective potency 
of UVB sunscreen against solar-simulated radiation (SSR)-i.nduced 
immunosuppression in which we determined immunologica lly 
relevant end points within the epidermis and skin-draining lymph 
nodes. '·2 On 6 consecutive days , hairless C3H mice (n = 5) were 
irradiated with SS.R (Mutzhas Supersun 5000 UV lamp equipped 
with a special filter system , 290 nm < A < 400 nm) with or without 
sunscreen protection (CO LIP A standard P1 [2. 7'Yc, octyl-methm.:-y-
cinnamate] vers11s placebo). On days 6-9, mice w e re topica ily 
exposed to the mode l contact allergen, oxazolone, on the dorsal 
surface of both ears to induce a primary CHS response. On day 10, 
ears and local draining lymph nodes were removed to assess lymph 
node ceil proliferation and activation of antigen-presenting cells , T 
ceils, and B cells in epidermal and lymph node ceil (LNC ) 
suspensions. Moreover, SSR-induced inflammation was assessed by 
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m easuring dorsal double skinfold tluckness. T he results obtained 
showed that the murin e SPF of3.7, based on skin edema, correlated 
well with a human SPF of 4, which was determined by skin 
erythema m easurement. Dose-response studies with unprotected or 
placebo-treated animals revealed that the MISD was comparable 
with 80% of the MIDunpmrccrcd· MJSD" and MIDb were determined 
as minimal significant "suppression of i11 JJ i JJo lymph node ceil 
proliferation or bi11crease in dorsal skin edema . Flowcytom etric 
analysis of epidermal cell and LNC suspensions showed that contact 
al le rgen-induced upregulation of co-stimulatory molecules, such 
as B7-1 and intercellular adhesion molecule-1, on I-A + epider-
mal cells and LNC was m arkedl y redu ced after irradiation with 
60% of the MIDunprurccrcd• whereas inftltration of CD4 + cells 
into the e pidermis was initi ally suppressed after exposure to 1 
MIDuup.-orccrcd· Moreover, oxazolone-induced upregulation of 
the inte rl eukin-2- receptor a - c hain (CD25) on CD4 + LNC was 
m au1tained up to irradiation with 1.5 MIDuupcorccrcd· ln compar-
ison, UVB sunscreen-protected mice exhibited a MISD of 60% 
of the M!D p.-orcctcd· Furthermore, this SSR dose dramati cally 
suppresse d co- stimulatory molecule expression on epide rmal 
cells and LN C and T - ce ll migration into th e epide rmi s. 
In recent yea rs, severa l studies have been performed rega rding 
protectiv e potency of sunscreen s aga inst UV -u1duced immuno-
suppression , and contrasting res ults have been publish ed (Wolf 
et a/, 1993; Bestak eta/ , 199 5, Roberts and Beasley, 1 99 5). So far, 
it is widely accepted that the ability of sunscreens to provide 
immunoprotection dep e nds critically on the dose of UV radia-
tion and can be overcome at high UV radiation doses. Further-
more, the spectrum of the li ght sow·ce is important u1 evaluating 
sunscree n efl:l cacy for any end point b eca use of the high 
sen sitivity of biologic e ffec ts of UVR to smail ch an ges at certain 
wavelengths. 
ln conclusion, w e agree with the investigators that dose-response 
curves for murine edema and human erythema are similar, although 
different light sources were used . Moreover, our fmdings confirm 
that UVB sunscreens protect only partially against UV-induced 
inununosuppression and that subedem al doses of UV radiation 
were able to indu ce substantial it!Ulmosuppression . In con trast to 
Walker and Young's fmding that UVB SPFs against UV-induced 
murine edema and in1munosuppression are the sa1ue, data from our 
study showed that the SPF against SSR-u1duced unmunosuppres-
sion was lower than the one against u1.fl ammation . Difl:"e rences 
between o u.r findu1gs and those ofWalker and Young might be due 
to tl1e use of diKerent li ght sources (monochromatic UVB JJersus 
SSR) and different end points. T hese contrasting results support the 
concept that UVA radiation plays a critical role in UV-induced 
immunosuppression. In our opinion , the use of SSR and the 
assessment of immunologically relevant end poults such as i11 JJiJJo 
lymph node cell proliferation and analysis of the activation of 
antigen-presenting cells (1-A + /CD80[B7-1] + , 1-A + /CD54[inter-
cellular adhesion molecule- 1] +) , T (CD4 + /CD25 +) , and B (I-A + I 
CD45R[B220] +) ceils in skin and sk.iJ1-draining lymph nodes 
during primary CHS responses, may be more appropriate to achieve 
results that could be extrapolated to humans exposed to sunlight. 
Finally, we would like to stress the conclusio n that complete 
immunoprotection will be achieved only by sunscreens witl1 broad-
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band absorption spectrum and a higher SPF than necessary for the 
prevention of erythema. 
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Reply: 
We thank Homey et a/ for their interest in our work. Their 
observations are correct. When we tested the ultraviolet B (UVB) 
sunscreen 2-ethylhel\.'Yl-4'-methol\.'Ycinnamate (2-EHMC) after a 
single challenge dose of2184 mj/cm 2 , there was a 33% suppression 
of the contact hypersensitivity (CI-IS) response (n = 8) as is shown 
in Fig 6 of our paper (Walker and Y ow1g, 1997). However, our 
dose-response studies (Fig 7) with suncreen application showed that 
the same dose resulted in about 10% suppression of CHS (n = 4) . 
This difference in the results (which was not significant; p = 0.2) 
m.ay be attributed to the smaller group size in the dose-response 
study; one. aberrant result with smaller sample sizes can significantly 
alter the group mean. Tlus is clear from the error bars (± SEM), 
which are larger than for the dose- response study. Furthermore, the 
challenge dose of 2184 mJ/cm2 is at the base of the "exponential" 
part of the sigmoid dose- response curve, where small variations in 
UVB dose (e.g., from an imal movement) are likely to result in 
proportionately larger errors . Our data demonstrate tl1at there is no 
significant difference in the shape of the dose- response curves for 
immunosuppression with or without sunscreen appli.cation once we 
allowed for attenuation ofUVB dose by the sunscreen according to 
its protection factor against edema. Failure to afford complete 
immunoprotection with our challenge dose of 2184 mJ/cm2 was 
due to a lower dose threshold for UVB-induced immunosuppresion 
compared with edema, despite similar protection factors for both 
end points. Our data emphasize the importance of dose-response 
studies ratl1er tl1a11 reliance on an arbitrary challenge dose of UV 
radiation (UVR), as is commonly done by some investigators. 
Homey et al have tested the protection afforded by the same UVB 
sunscreen [sun protection factor (SPF) = 4] against solar simulated 
radiation-induced immunosuppression using by six successive ex-
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posures to solar-stim ul ated radiation (SSR) (Mutzhas Supersun 
5000) . They confirm our observations that murine edema is a good 
model for human erythema and that the dose threshold for 
UVR-induced immunosuppression (using different end poin ts) is 
lower than that for inflammation. In contrast to our data, th ey 
report that protection against immunosuppression is lower than that 
for inflarnmation. W e look forward to the publication of their 
studies, but in the meantime it is difficult to make a comment 
without a more detailed account of their experimental protocol 
than is given in their abstracts. However, they have assessed the 
SPF for immunoprotection after multiple SSR exposures, which 
cannot be readily compared with the presumed more conventional 
assessment of inflammation after a single exposure . For example, it 
is possible that multiple suhedernal doses ofUVB m ay cumulatively 
induce significant immunosuppression, as other workers have 
demonstrated that immunosuppression (suppression ofCHS) in the 
mouse is independent of dose fractionation (Noonan et a/, 1981 ). 
T hus we cannot agree with Homey el a/ that the lower SPF for 
immunosuppression necessarily indicates that UV A plays a critical 
role in immunosuppression . 
Homey et al correctly state the importance of using SSR. 
However, the emission spectrum of the M.utzhas Supersun source 
that they used is a rather poor simulation of solar UVR (a 
continuum), as it contains several high-intensity monchromatic 
spilces. W e would like to stress that we chose an essentially 
monochromatic UVB source (PluJips TL01 tubes) so that the 
absorption spectra of the UVB sunscreens we used completely 
overlapped the emission spectrum of the source. This ensured that 
the observed su ppression ofCHS was not due to UVR wavelengths 
transmitted by the sunscreen . Our aim was to study the reported 
apparent lack of correlation between sunscreen photoprotection of 
inflammation and immunosuppression. The use of a monochro-
matic source eliminated any confounding factors due to possible 
differences i11 the action spectra of edema and immunosupression . 
Sunscreens are routinely evaluated by their ability to prevent 
erythema from a. single SSR exposure. lf we are to determine the 
role of sunscreen photoprotection against solar UVR- induced 
immunosuppression, we must determine the relationships between 
SSR-induced erythema and immunosuppression in humans . Fur-
thermore, it is also important to esta blish the effect of chronic 
suberythemal SSR exposure on the induction of both these end 
points . We do agree with Ruzicka et al, however, that incomplete 
immunoprotection requires a lugher SPF than is necessary for the 
prevention of erythema . T his holds true when the dose threshold 
for immunosuppression is lower than that for erythema even if, as 
demonstrated by us, the protection end points are the same. 
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